Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{187506,
        author = {Chandana Mantha and Suvarna Kasi and Madhavilatha and Uma Devi},
        title = {Method Development and Validation of Emtricitabine and Tenofovir Disoproxil Fumarate by RP-HPLC Method},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {6},
        pages = {5606-5611},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=187506},
        abstract = {A simple, precise, and accurate reverse-phase high-performance liquid chromatography (RP-HPLC) method was developed for the simultaneous estimation of Emtricitabine and Tenofovir Disoproxil Fumarate in bulk and in pharmaceutical dosage forms using a Waters HPLC system. Chromatographic separation was achieved on an Inertsil ODS C18 column (250 × 4.6 mm, 5 µm particle size) maintained at ambient temperature. The mobile phase consisted of water and methanol in the ratio of 85:15 (v/v). The flow rate was maintained at 1.0 mL/min, and detection was carried out at 261 nm using the PDA detector.},
        keywords = {Emtricitabine and TDF (Tenofovir Disoproxil Fumarate), RP-HPLC.},
        month = {November},
        }